1. CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial. (14th June 2015) Authors: Fijal, Bonnie A.; Guo, Yingying; Li, Si G.; Ahl, Jonna; Goto, Taro; Tanaka, Yoko; Nisenbaum, Laura K.; Upadhyaya, Himanshu P. Journal: Journal of clinical pharmacology Issue: Volume 55:Number 10(2015:Oct.) Page Start: 1167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗